Rayonier Advanced Materials 3Q 2026: Revenue $382.51M, Net income ($229.77M), EPS ($3.4) — 10-Q Summary

Rayonier Advanced Materials reported 3Q 2026 revenue of $382.51M, up 8.4% YoY, but net loss widened to $229.77M. EPS loss was $3.4. Sales growth was driven by higher cellulose specialties pricing and increased volumes. The company idled uneconomic operations at Temiscaming and is targeting CS-focused production growth. A strategic review is expected to complete in Q1 2027.

Original reporting
Published Nov 4, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rayonier Advanced Materials 3Q 2026: Revenue $382.51M, Net income ($229.77M), EPS ($3.4) — 10-Q Summary — source image
Decision brief

The 30-second read

$RYAMBearishHigh
01

Why it matters

The earnings miss is likely to drive short‑term downside pressure, though the strategic review announced for early 2027 may offer a longer‑term catalyst.

02

Market read

Primary earnings disclosure for a niche U.S. chemical firm; immediate relevance for traders with exposure to specialty chemicals.

03

What to watch

Tariff relief or cost reductions at the Temiscaming site could mitigate the loss if the idled plant reopens.

Relevance 8/10Novelty 8/10Timing: post-market release

Background

Rayonier Advanced Materials (RYAM) filed its Q3 2026 10‑Q, reporting revenue growth but a steep net loss and operational challenges at its Temiscaming facility.

Company-level read

Ticker impact

$RYAMBearishHigh confidence
Context

Quarterly 10-Q disclosed Q3 2026 revenue of $382.5M and a net loss of $229.8M, a material earnings surprise.

Expected impact

downward pressure as investors price in the unexpected loss

Evidence & confidence

The company reported a 5058% YoY loss, far worse than prior-year quarter, indicating deteriorating profitability.

Market effects

Signals weakness in the cellulose specialties segment, potentially affecting peers in the specialty chemicals space.

U.S. specialty chemicals sector may see modest pullback.

Limited to investors tracking niche pulp and cellulose producers.

Counterpoint

The company’s strategic review and focus on high‑purity cellulose could enable a turnaround if execution improves.

Key entities

  • Rayonier Advanced Materials

    U.S.-listed specialty chemicals producer (ticker RYAM).

  • Verso Energy

    Partner in the Tartas e‑SAF project.

Related articles

$RYAMMedAI 8/10

Rayonier Advanced Materials Q3 Earnings Call Highlights

Rayonier Advanced Materials (RYAM) reported Q3 net sales of $383M, up 2% sequentially and 8% YoY. Adjusted EBITDA rose to $52M. High Purity Cellulose sales increased, while Paperboard & High Yield Pulp sales declined. The company is focusing on its Cellulose Specialties franchise and expects positive free cash flow for 2026, subject to certain conditions.

$RYAMMed

Rayonier Advanced Materials Inc (RYAM) Q3 2026 Earnings Call Highlights: HPC Segment

Rayonier Advanced Materials (RYAM) reported Q3 2026 net sales of $383M, up 2% sequentially and 8% YoY. Adjusted EBITDA rose 30% to $52M. CEO Dan Kraupchak discussed strategic plans, including optimizing production mix and pursuing longer-term customer agreements. CFO Marcus Moltner noted $4M energy credits and $2M tariff-related costs. CS volumes are expected to exit the year at ~100,000 metric tons per quarter. Liquidity stands at $143M, with positive adjusted free cash flow of $2M YTD.

$RYAMMed

RYAM Reports Third Quarter 2026 Results

RAYONIER ADVANCED MATERIALS INC. (RYAM) filed an SEC Form 8-K — Results of Operations and Financial Condition. RYAM Reports Third Quarter 2026 Results Delivers 30% sequential growth in Adjusted EBITDA Temiscaming production economically idled following U.S. tariffs • Loss from Continuing Operations of $229 million adjusted for non-cash impairments of $221 million was $8 million, a 60% seq

$RYAMHighAI 8/10

RYAM Reports Third Quarter 2026 Results

Rayonier Advanced Materials (RYAM) reported Q3 2026 results. HPC income rose to $29M with Adjusted EBITDA of $44M, while Temiscaming operations were idled. Consolidated Adjusted EBITDA was $52M, including tariff costs. The company aims to conclude its strategic review in Q1 2027. Net sales were $383M, with HPC at $313M and Paperboard & High Yield Pulp at $70M. Operating loss was $196M, including non-cash impairments. Year-to-date Adjusted Free Cash Flow was $66M.

$RYAMMed

Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another Story

Rayonier Advanced Materials (RYAM) reported Q2 net sales of $376M, up 18% QoQ and 11% YoY, with a narrowed loss of $33M. High Purity Cellulose segment saw a 21% YoY price increase, boosting operating income by 45%. However, Cellulose Specialties volume fell 23% YoY. Management maintains a 2026 outlook for positive free cash flow and targets Q4 2026 for a strategic review conclusion.

$RYAMMedAI 8/10

Rayonier (RYAM) Q2 2026 Earnings Call Transcript

Rayonier Advanced Materials (RYAM) reported Q2 2026 net sales of $376 million, up 18% sequentially and 11% year over year. Adjusted EBITDA rose to $40 million. Loss from continuing operations was $33 million. Management reiterated full-year positive free cash flow guidance and said its strategic alternatives review will conclude in Q4 2026.